drug costs

Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.

The Inflation Reduction Act gives Medicare historic new powers to limit prescription drug prices. But the pharmaceutical industry is already lobbying to dull their impact.

The lawsuit, filed in federal court in Tampa, came after AHCA Secretary Simone Marstiller submitted a Freedom of Information Act request seeking numerous records about importation proposals by Florida and other states.

The bill enables the federal health secretary to negotiate the prices of some drugs for Medicare. It also caps out-of-pocket prescription drug costs for people on Medicare at $2,000, effective in 2025.

A divided Congress gave final passage to Democrats’ flagship climate and health care bill.

President Biden is urging swift House passage, and the House seems on track to provide final congressional approval when it returns briefly from summer recess on Friday.

West Virginia Sen. Joe Manchin reached an agreement with Senate Majority Leader Chuck Schumer that had eluded them for months on health care costs, energy and climate issues.

The governor's order requires state agencies to review contracts with pharmacy benefit managers to ensure that costs are justified. He also expressed disappointment over the FDA's delay in approving Canadian drug imports.

A local chapter of the Alliance for Retired Americans wants Sens. Rick Scott and Marco Rubio to support legislation that would decrease health care and prescription drug costs for seniors.

Perspective: Amid skyrocketing drug prices, it’s understandable that patients desperately need help affording medicine, especially when their health is on the line. But these programs create a mirage that perpetuates our health care system’s reckless spending.